Bradsaúde (SAUD3) Status update summary
Event summary combining transcript, slides, and related documents.
Status update summary
28 Jan, 2026Business model and market position
Operates exclusively in dental care, with a digital, asset-light model and nationwide coverage, serving over nine million clients and nearly 30,000 dentists.
Maintains market leadership for over 20 years, with a focus on large corporate contracts but expanding into small and medium enterprises (SMEs).
Technology and data analytics are core competitive advantages, enabling high efficiency, quality control, and fraud reduction.
Partnerships with major banks, especially Bradesco and Banco do Brasil, provide exclusive distribution channels and access to new client segments.
The company’s cost structure is highly efficient, with costs below 40% of revenue, supported by ongoing investments in technology.
Financial performance and growth outlook
Margins have expanded from 49% to around 62% due to a shift in client mix toward SMEs and individuals, which offer higher profitability.
Growth is expected to continue, especially in the SME segment, though overall revenue growth is currently in the mid-single digits.
The company operates with zero debt and a strong cash position, distributing nearly all profits as dividends or share buybacks.
Financial income is partially protected from interest rate declines due to a mix of long-term IPCA-linked investments and short-term Selic exposure.
Efficiency gains from technology investments are expected to further improve margins and offset any reduction in financial income.
Dividend policy and shareholder returns
Has distributed an average of 95% of profits as dividends over the past decade, with a strong commitment to regular and high payouts.
Dividend yield typically ranges from 8% to 10%, combining dividends, interest on capital, and occasional share buybacks.
Maintains flexibility in dividend payment timing, prioritizing financial prudence and strategic needs.
Predictability and sustainability of dividends are supported by a stable business model, zero leverage, and prepaid contracts.
Latest events from Bradsaúde
- Net income up 15% in 3Q24, with margin expansion and 100% payout to shareholders.SAUD3
Q3 20249 Jul 2026 - Net income was R$1.3B in 1Q26, with 13M+ members and major hospital and digital expansion.SAUD3
Q1 20268 Jul 2026 - Revenue up 5.3%, net income up 4.1%, 83% payout, and strong net cash with zero debt.SAUD3
Q4 20256 Jul 2026 - Record SME growth and margin expansion drove strong revenue and net income gains.SAUD3
Q3 20256 Jul 2026 - Net income up 18.1% YoY, record EBITDA margin, and robust SME-driven growth.SAUD3
Q2 20256 Jul 2026 - Adjusted EBITDA margin rose to 38.3% in 1Q25, led by SME and Individual plan growth.SAUD3
Q1 20256 Jul 2026 - Revenue up 5.9%, net income R$539M, 97% payout, R$913M net cash, no debt.SAUD3
Q4 20242 Jul 2026 - 2Q24 delivered strong growth, record margins, and a 100% net income payout to shareholders.SAUD3
Q2 20242 Jul 2026